after two years of follow-up , 71 % of preclinical ( category-c ) patients had developed signs , symptoms or evidence of immune dysfunction , and 12 % of those patients with lymphadenopathy or with other early clinical features of disease ( category-b ) had progressed to the acquired immunodeficiency syndrome ( aids ) .
C0021053
immune dysfunction
C0497156
lymphadenopathy